Authors


Hilary Baldwin, MD

Latest:

Advances and Challenges in Rosacea Treatment: Insights From Hilary Baldwin, MD

At the 2024 SDPA Fall Conference, Hilary Baldwin, MD, highlighted innovative strategies for managing complex rosacea cases, the importance of combination approaches, and a slowing treatment pipeline.


Courtney Marabella

Latest:

Topical Remetinostat Effective, Tolerable in Basal Cell Carcinoma

The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.


Adam Braunscheidel, CFP

Latest:

Residency Is Ending Soon: Key Financial Tips for Your Next Chapter

From a financial perspective, the change from resident to attending dermatologist may be profound.


Elizabeth Swanson, MD

Latest:

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.


Maryanne Makredes Senna, MD

Latest:

Navigating Challenges and Advancements in Alopecia Areata Treatment

Maryanne Makredes Senna, MD, shares insights into the complexities of treating alopecia areata and guidance for clinicians.


Giuliana Grossi

Latest:

Severity of Psoriatic Disease Significantly Associated With Risk of Inflammatory Bowel Disease

A recent study identified an association between psoriasis severity and IBD, Crohn disease, and ulcerative colitis.


Amanda L. Michaud, PA-C

Latest:

Tips for Difficult to Control Chronic Spontaneous Urticaria

Amanda L. Michaud, PA-C, shares insights on difficult to control chronic spontaneous urticaria at the ACAAI Annual Scientific Meeting.




Jason Luke, MD, FACP

Latest:

New Long-Term KEYNOTE-716 Data Presented at ASCO 2023

Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.


Russ Conroy

Latest:

Cancer Vaccine Plus Keytruda Improves Survival Without Relapse in Resected Melanoma

Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.


Volker Koscielny, MD, MBA

Latest:

Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin Academy

López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.


Cameron Santoro

Latest:

Improving Hidradenitis Suppurativa Outcomes by Addressing Treatment Gaps

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among patients.


Lilia Correa-Selm, MD, FAAD, FACMS

Latest:

Expert Perspectives on BOLT clinical trial data

John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.



Boni Elewski, MD

Latest:

Resources for Patients With GPP

Boni Elewski, MD, shares resources for patients with GPP, highlighting a team-based approach to meet the psychological and physical needs of the patient.


Gina Mauro

Latest:

FDA Grants Orphan Drug Status to ITIL-168 for Melanoma

The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.


Atoosa Kourosh, MD, MPH

Latest:

Navigating Nutrition Support For Patients With Atopic Dermatitis

Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.




Kristina Collins, MD

Latest:

Finding Balance in a Busy Conference Season

Kristina Collins, MD, delves into the importance of being present in the moments you have control over and making self-care a priority on the road.


Carrie Nagorka, Senior Editor

Latest:

Preparing Patients for the Summer Sun: Location, Location, Location

Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.


Brandon May

Latest:

Acne Flares May be Worsened by Climate Change

Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.


Sherry G. Cohen, NP-C

Latest:

Treating Seborrheic Dermatitis

A look at the common condition and how to treat it.



Amit Pandya, MD

Latest:

Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAAD

Pandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.


Raj Chovatiya, MD, PhD, MSCI

Latest:

Systemic Treatment Options for Atopic Dermatitis

The panelist discusses how systemic atopic dermatitis (AD) treatment involves biologics and Janus kinase inhibitors for moderate to severe cases, targeting inflammation and itch with individualized approach based on patient factors, offering significant symptom improvement and skin barrier restoration.


Ron Southwick

Latest:

Female physicians earn millions less than male counterparts, new report finds

A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.


Victor L. Quan, MD

Latest:

Acne Update: 2022’s Top 5 Trends

Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.


Özge Uluçkan, PhD

Latest:

Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HS

Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.

© 2025 MJH Life Sciences

All rights reserved.